Evidence map›Paper›PMID 24522264›Full record

ArticleThe ISME journal2014

Human milk oligosaccharides shorten rotavirus-induced diarrhea and modulate piglet mucosal immunity and colonic microbiota.

Min Li, Marcia H Monaco, Mei Wang, Sarah S Comstock, Theresa B Kuhlenschmidt, George C Fahey, Michael J Miller, Mark S Kuhlenschmidt, Sharon M Donovan

Open access · bronzeAbstract read
In one paragraph

Article in The ISME journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 1 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 1 synthesis or guideline pooled it, 164 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Farnesoid X Receptor Agonist Tropifexor Improves Intestinal Defense Response and Epithelial Barrier Function in Neonatal Piglets Receiving Parenteral Nutrition.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  7. Article
  8. Review
  9. International journal of molecular sciences · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Diagnosing and engineering gut microbiomes.EMBO molecular medicine · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Antimicrobial Properties of Colostrum and Milk.Antibiotics (Basel, Switzerland) · 2024
    Review
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Min LiDepartment of Food Science and Human Nutrition, University of Illinois, Urbana, IL, USA.
Marcia H MonacoDepartment of Food Science and Human Nutrition, University of Illinois, Urbana, IL, USA.
Mei WangDepartment of Food Science and Human Nutrition, University of Illinois, Urbana, IL, USA.
Sarah S ComstockDepartment of Food Science and Human Nutrition, University of Illinois, Urbana, IL, USA.
Theresa B KuhlenschmidtDepartment of Pathobiology, University of Illinois, Urbana, IL, USA.
George C FaheyDepartment of Animal Sciences, University of Illinois, Urbana, IL, USA.
Michael J MillerDepartment of Food Science and Human Nutrition, University of Illinois, Urbana, IL, USA.
Mark S KuhlenschmidtDepartment of Pathobiology, University of Illinois, Urbana, IL, USA.
Sharon M DonovanDepartment of Food Science and Human Nutrition, University of Illinois, Urbana, IL, USA.
University of Illinois Urbana-Champaign · US

Funding

Mechanisms by which Human Milk Oligosaccharides Protect Against RotavirusR01HD061929 · NICHD · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI DONOVAN, SHARON MARIE · 2009 to 2012
$1.3M
NICHD NIH HHS R01 HD061929
6 · The paper itself

Abstract

The impact of human milk oligosaccharides (HMO) on mucosal immunity, gut microbiota and response to rotavirus (RV) infection was investigated in the piglet model. Newborn piglets were fed with formula alone (FF) or formula supplemented with 4 g l(-1) HMO (HMO) or a prebiotic mixture of 9:1 short-chain galactooligosaccharides (3.6 g l(-1)) and long-chain fructooligosaccharides (0.4 g l(-1)) (PRE) (n=19-21 per group) for 15 days. Piglets (n=7-8) in each dietary group were orally infected with porcine rotavirus (RV) OSU strain on d10, and stool consistency was assessed daily. Blood, small intestine and colonic contents were collected at day 15. Serum RV-specific antibody concentrations, intestinal histomorphology, RV non-structural protein-4 (NSP4) and cytokine mRNA expression were assessed. Colonic content pH, dry matter (DM) and short-chain fatty acid concentrations were measured. Ascending colonic microbiota was analyzed by 16S rRNA gene v1-3 region pyrosequencing. HMO- and PRE-fed groups had shorter duration of diarrhea than FF piglets. Infection changed intestinal histomorphology, increased serum RV-specific antibody response and intestinal RV NSP4 expression, and modulated ileal cytokine expression. HMO enhanced T helper type 1 (interferon-gamma) and anti-inflammatory (interleukin-10) cytokines in the ileum, while prebiotics promoted RV-specific immunoglobulin M response to the infection. RV infection and HMO supplementation altered intraluminal environment and gut microbiota. HMO increased pH and lowered DM of colonic contents and enhanced the abundance of unclassified Lachnospiraceae, which contains numerous butyrate-producing bacteria. In conclusion, HMO and prebiotics did not prevent the onset of RV infection but reduced the duration of RV-induced diarrhea in piglets, in part, by modulating colonic microbiota and immune response to RV infection.

Indexed as

Immunity, MucosalMicrobiotaAnimalsColonDiarrheaHumansIntestine, SmallMilk, HumanOligosaccharidesPrebioticsRotavirusRotavirus InfectionsSwineOligosaccharidesPrebiotics

Identifiers

PMID24522264
PMCPMC4817601
OpenAlexW2075612853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.